Johannes Fruehauf
President and Co-Founder @ Volnay Therapeutics
Cambridge, United States
Johannes Fruehauf is a startup investor at Volnay Therapeutics in Cambridge. Johannes Fruehauf is the President and Co-Founder of Volnay Therapeutics. He previously worked at Sentien Biotechnologies, Inc. as a Board Director. Johannes Fruehauf attended Harvard Medical School.
Last updated:
For AI agents: llms.txt
About Volnay Therapeutics
Volnay Therapeutics is a biotech company, which is committed to hastening the creation of novel gene and cell medicines. Having worked in drug development for decades, Volnay finds promising therapeutic assets and revolutionary enabling technologies and offers funding and operational know-how to support these initiatives. With an emphasis oncapital efficiency, economic viability, and product manufacturing innovation, Volnay hopes to provide substantial value to both investors and patients.
Volnay Therapeutics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Johannes Fruehauf
President and Co-Founder
|
|||
Nebojsa Milovic
CTO and Co-Founder
|
|||
Stefan Wildt
CEO & Co-Founder
|
|||
Ulrik B. Nielsen
Co-founder and Executive Chairman
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
